Vimarsana
Biggest News Aggregation in the World

Page 37 - Wave Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wave Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wave Life Sciences Today - Breaking & Trending Today

StockNews.com Initiates Coverage on Wave Life Sciences (NASDAQ:WVE) - Vimarsana News

StockNews.com Initiates Coverage on Wave Life Sciences (NASDAQ:WVE)

StockNews.com started coverage on shares of Wave Life Sciences (NASDAQ:WVE – Get Rating) in a research report report published on Thursday. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and set a $10.00 price objective on shares of Wave Life Sciences in a research note on Friday, […]

GSK partners with LifeMine as startups advance plans to make drugs from fungi - Vimarsana News

GSK partners with LifeMine as startups advance plans to make drugs from fungi

BioPharma

Wave Life Sciences Ltd. (NASDAQ:WVE) Expected to Post Quarterly Sales of $3.75 Million - Vimarsana News

Wave Life Sciences Ltd. (NASDAQ:WVE) Expected to Post Quarterly Sales of $3.75 Million

Equities research analysts expect Wave Life Sciences Ltd. (NASDAQ:WVE – Get Rating) to report sales of $3.75 million for the current quarter, Zacks reports. Four analysts have issued estimates for Wave Life Sciences’ earnings, with the highest sales estimate coming in at $5.50 million and the lowest estimate coming in at $2.00 million. The business […]

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Sold by Squarepoint Ops LLC - Vimarsana News

Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC cut its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Get Rating) by 41.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,080 shares of the company’s stock after selling 14,445 shares during the period. […]

Wave Life Sciences Reports Preclinical Proof of Concept for RNA Base Editing - Vimarsana News

Wave Life Sciences Reports Preclinical Proof of Concept for RNA Base Editing

Wave Life Sciences researchers have published positive preclinical proof-of-concept data showing the company’s adenosine deaminase acting on RNA (ADAR)-mediated RNA base editing technology to deliver potent, durable, and specific edits in non-human primates (NHPs)—as well as a broader potential for therapeutic applications in the liver.